Interleukin receptor expression inhibiting antisense oligonucleotides
US5135917A · kind A · utility
125Cited by
2References
10Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jul 12, 1990 |
| Grant date | Aug 4, 1992 |
| Priority date | — |
| Expiry date | Jul 12, 2010 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2310/315
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed are oligonucleotide compounds that inhibit interleukin receptor expression when administered to a human subject. Also disclosed are pharmaceutical compositions and methods for inhibiting human interleukin receptor expression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.